This document discusses hypoglycemia in neonates. It defines neonatal hypoglycemia as a plasma glucose level below 30 mg/dL in the first 24 hours of life or below 45 mg/dL thereafter. It identifies factors that increase hypoglycemia risk, such as low birth weight, prematurity, and maternal diabetes. Symptoms are nonspecific but include poor feeding, temperature instability, and central nervous system issues. Treatment involves glucose boluses and maintenance with intravenous dextrose infusions. Resistant or persistent hypoglycemia may require higher infusion rates, hydrocortisone, glucagon, or other drugs. Careful glucose monitoring is important to prevent neurological complications.
pediatrics emergency, hypoglycemia of infancy.
Glucose level can drop if:
There is too much insulin in the blood (hyperinsulinism). Insulin is a hormone that pulls glucose from the blood.
The baby is not producing enough glucose.
The baby's body is using more glucose than is being produced.
The baby is not able to feed enough to keep glucose level up.
Hypoglycemia in the Newborn - Ashish Jain & Rajiv Aggarwal & M. Jeeva Sankar &Ramesh Agarwal & Ashok K. Deorari & Vinod K. Paul- Indian J Pediatr (2010) 77:1137–1142- Artigo apresentado e discutido em reunião científica da Liga Acadêmica de Pediatria da UFRN - LAPED UFRN - Natal - Brasil.
Neonatal hypoglycemia and hyperglycemia Dr vijitha ASVijitha A S
Neonatal hypoglycemia and hyperglycemia BY Dr VIJITHA A S
Hypoglycemia is most common metabolic problem seen in newborns
No universally accepted definition ; Hypoglycemia cut off variable
pediatrics emergency, hypoglycemia of infancy.
Glucose level can drop if:
There is too much insulin in the blood (hyperinsulinism). Insulin is a hormone that pulls glucose from the blood.
The baby is not producing enough glucose.
The baby's body is using more glucose than is being produced.
The baby is not able to feed enough to keep glucose level up.
Hypoglycemia in the Newborn - Ashish Jain & Rajiv Aggarwal & M. Jeeva Sankar &Ramesh Agarwal & Ashok K. Deorari & Vinod K. Paul- Indian J Pediatr (2010) 77:1137–1142- Artigo apresentado e discutido em reunião científica da Liga Acadêmica de Pediatria da UFRN - LAPED UFRN - Natal - Brasil.
Neonatal hypoglycemia and hyperglycemia Dr vijitha ASVijitha A S
Neonatal hypoglycemia and hyperglycemia BY Dr VIJITHA A S
Hypoglycemia is most common metabolic problem seen in newborns
No universally accepted definition ; Hypoglycemia cut off variable
Nursing Management · Monitor blood sugar and use a sliding scale to treat high levels of glucose · Educate patient about diabetes · Examine feet .
Diagnosis involves measuring blood glucose levels. Ongoing specialized assessment and evaluation for complications are essential for diabetes management.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
2. Introduction
• Glucose or dextrose is a vital source of nutrient energy and is required
continuously by the fetus.
• Neonate needs this as either intermittent oral feeds or continuous IV fluids.
• Hypoglycemia can cause long term neurologic sequelae.
• The important steps in preventing and treating hypoglycemia are
• to identify neonates at risk of developing hypoglycemia
• to recognize symptoms of hypoglycemia, early feeding and
• to initiate IV fluid therapy, where ever needed.
3. Definition of hypoglycemia
• Neonatal hypoglycemia, defined as a plasma glucose level of less than 30
mg/dL (1.65 mmol/L) in the first 24 hours of life and less than 45 mg/dL (2.5
mmol/L) thereafter,
• Neonatal hypoglycemia is the most common metabolic problem in
newborns.
4. Symptoms of hypoglycemia
• The symptoms of hypoglycemia are very nonspecific
• The common symptoms are:
• Not looking well
• Lethargic
• Weak cry
• Poor feeding
• Temperature instability like hypothermia
• Poor respiratory effort: shallow breathing, apnea orcyanosis
• CNS symptoms like: excessive jitteriness, convulsions or hypotonia
5. Factors which increase the risk of hypoglycemia
• Various factors which increase the risk of hypoglycemia are hypothermia &
cold Stress, cold environment, wet baby and inadequate feeding.
6. Neonates at risk of hypoglycemia
• Babies weighing less than 2.0 kg birth weight
• preterm babies
• LGA (large for gestational age) babies especially those weighing more than
3.5 kg
• infants of diabetic mothers
• those with delayed cry at birth, any sick neonate who is not sucking or
accepting feeds are all at risk of developing hypoglycemia
• The other risk factors for hypoglycemia are RDS, polycythemia, shock, and
hypothermia
7. Etiology
• The causes of neonatal hypoglycemia include the following:
• Persistent hyperinsulinemic hypoglycemia of infancy (PHHI)
• Limited glycogen stores (eg, prematurity, intrauterine growth retardation)
• Increased glucose use (eg, hyperthermia, polycythemia, sepsis, growth
hormone deficiency)
• Decreased glycogenolysis, gluconeogenesis, or use of alternate fuels (eg,
inborn errors of metabolism, adrenal insufficiency)
• Depleted glycogen stores (eg, asphyxia-perinatal stress, starvation)
8. hypoglycemia ketotic and nonketotic
Ketotic hypoglycemia
1. Metabolic disorders
Non-Ketotic hypoglycemia
Organic acidurias
Inbom errors of glycogenolysis
Inbom errors of gluconeogenesis
2. Cortisol deficiency
3. Growth hormone deficiency
4. Starvation
Non-Ketotic hypoglycemia
1.Metabolic disorders
Disorders of beta Oxidation of fatty
acids
2. insulinoma
9. Treatment
• To raise the blood sugar value to normal range, give 200 mg/kg of dextrose
i.e. 2 ml/kg of 10% dextrose as bolus slowly over 3-5 minutes and start
maintenance fluids with a dextrose infusion rate (DIR) of 6-8 mg/kg/min.
• The maximum strength of dextrose that can be given through a peripheral
vein is 12.5%.
• Repeat Dextrostix after 15-30 minutes, if still low, repeat bolus and increase
(DIR) by 1-2 mg/kg/min or the maintenance fluids by 10-20 ml/kg/day.
• For example in a low birth weight baby on first day of life give 80ml/kg/day
i.e. 80 x wt of the baby
• e.g. 1.8 kg i.e. 144 ml/day. Divide by 24 to obtain fluid per hour (144/24 = 6
ml/hr)
10. • Take a measured volume set, fill 1/4th or 6 hrs fluid i.e. 24 ml and deliver at a
rate of 6 micro drops/min (number of drops per minute is equal to rate of
fluid/hour)
• The dextrose infusion rate can be calculated by the following formula:
• Fluid rate (ml/kg/day) x % of Dextrose to be used x 0.007 = DIR (mg/kg/min)
• e.g. If a baby is on 100 ml/kg/day of 10% dextrose, the DIR is 7 mg/kg/min.
You may also use the reference charts to calculate the DIR.
11. How to monitor blood glucose in hypoglycemia
• In asymptomatic babies measure blood glucose within 2 hrs of birth,
preferably before feeds.
• Frequency & duration depends on clinical features and glucose value, initial
frequency may be 2 hrly, and later 4 hrly and finally 8 - 12 hrly.
• Monitoring is usually done for 72 hrs after birth in at risk newborns or till
glucose levels remain normal for 48-72 hrs.
• Symptomatic babies: may require more frequent monitoring.
• Maintain the same DIR till the blood glucose is stable for at least 6- 8hrs and
then decrease the DIR by not greater than 1-2 mg/kg/min every 2 hours with
adequate monitoring
12. Resistant and Persistent Hypoglycemia
• Resistant or Persistent Hypoglycemia:
• Requirement of a dextrose infusion rate or more than 12 mg/kg/min
suggests resistant hypoglycemia.
• Any hypoglycemia persisting beyond one week despite adequate
management suggests persistent hypoglycemia.
• One should rule out hyperinsulinemic state or inborn errors of metabolism.
• Increase the DIR to 12-15 mg/kg/min, keeping in mind that more than 12.5%
dextrose should not be given through a peripheral vein and a central venous
catheterization is required.
• In resistant or persistent hypoglycemia the following drugs should be
considered:-
• Hydrocortisone: 10 mg/kg/day in two divided doses intravenously
13. • Glucagon: 100-300 ug/kg/dose IM to a maximum of 3 doses in babies with
adequate glycogen stores
• Diazoxide: 2-5 mg/kg/dose every 8 hrly orally
• Octreotide: Synthetic somatostatin in a dose of 2-10 ug/kg/day
subcutaneously q 8-12 hourly
• Babies with persistent or resistant hypoglycemia should be REFERRED to a
specialize center for farther investigations
14. Conclusion
• Awareness of risk factors that predispose infants to hypoglycemia allows for
screening of those at risk.
• If detected hypoglycemia can be treated promptly, thereby preventing the
development of severe or symptomatic hypoglycemia, which is associated
with adverse outcome.
• Asymptomatic hypoglycaemia: It is likely that hypoglycemia contributes to
abnormal neurodevelopmental outcome in infants with other risk factors for
brain injury, such as prematurity